跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Mupiriv
Approved
STANDARD
Mupiriv
East African (India) Overseas
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
318aaa1808b80350
Company
East African (India) Overseas
Type
Standard
Approval Details
Approval Id
318aaa1808b80350
Drug Approval Philippines Name
Mupiriv
Product Name
Mupiriv
Registration Number
DRP-13828
Brand Name
Mupiriv
Generic Name
Mupirocin
Dosage Form
Topical Ointment
Dosage Strength
20 mg/g (2% w/w)
Manufacturer
East African (India) Overseas
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
27 April 2023
Expiry Date
27 April 2028
Pharmacologic Category
Antibacterial
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
318aaa1808b80350
Type
Standard
Back to Philippines FDA Approvals
Mupiriv - Philippines FDA Drug Approval Details